Bayer Ophthalmology ‘16 weeks’

In the UK, Bayer’s ‘nAMD’ retinal disease drug EYLEA 2mg had been licensed to 16 weeks and HCPs could now extend their patients out to 16 weeks for the first time.

To let HCPs, payers and patients aware of this incredible step in treatment, Bayer wanted an engaging, overarching idea that could be used across multiple channels and touch points, from an online film to digital banners to a Congress booth.

The result was Bayer UK’s most successful tactical campaign for EYLEA 2mg, with a 23% increase in enquiries, a 17% increase in rep visit requests and an uptake in the drug to cement its position as the brand leader.

Awards:

PM Awards - Film and Animation

RCO Congress - Best in Show.